Rituxan (rituximab) - Roche
Rituximab Outcomes and Predictors of Treatment Failure in Primary Membranous Nephropathy: A Retrospective Cohort Study. (PubMed, J Clin Med) - Sep 27, 2026 - "Baseline anti-PLA2R antibody levels and serum albumin provided complementary prognostic information. Previous treatment status was not associated with remission or treatment failure at the predefined 9-month assessment and was not independently associated with failure-free survival after adjustment for baseline serum albumin, although this finding should be interpreted cautiously given the limited sample size and unequal follow-up." 
Journal • Retrospective data • Glomerulonephritis • Infectious Disease • Renal Disease
http://www.ncbi.nlm.nih.gov/pubmed/42795840
 
Alparslan Ersoy; Cuma Bülent Gül; Esra Celik; Halime Soyak Kabaca; Mustafa Güllülü; Saide Elif Güllülü Boz
 
Sep 27, 2026
 
Prev Next